gip glp 1 agonist tirzepatide Frontiers GLP1-GIP receptor co-agonists: a promising

Research-planning notes recommend heart-rate tracking during the first 12 weeks, particularly for those with cardiovascular history consult a clinician

Type 2 diabetes drug Ozempic continues to make headlines

This is why your doctor may lower your dose if you have side effects that are difficult to tolerate

Perhaps most importantly, robust clinical evidence supporting strict discontinuation thresholds in CKD are currently lacking

Does tirzepatide actually cause insomnia

Heart Health: In 2026, semaglutide is uniquely recommended for those with a BMI over 27 and cardiovascular risks, offering protection that fasting alone cannot match